Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,697,157 papers from all fields of science
Search
Sign In
Create Free Account
caracemide
Known as:
Acetamide, N-[(Methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]-(9CI)
, Acetamide, N-[(methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]- (9CI)
, N-Acetyl-N-(methylcarbamoyloxy)-N'-methylurea
An agent derived from acetohydroxamic acid with potential antineoplastic activity. Caracemide inhibits ribonuclease reductase, resulting in decreased…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
analogs & derivatives
Broader (1)
hydroxyurea
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Phase I trial of caracemide using bolus and infusion schedules.
M. Raber
,
F. Adams
,
J. Kavanagh
,
S. Legha
,
I. Dimery
,
I. Krakoff
Cancer treatment reports
1987
Corpus ID: 29652542
We conducted a phase I trial of caracemide, a new chemotherapeutic agent, which is active in the MX1 (mammary) and CX1 (colon…
Expand